XML 57 R44.htm IDEA: XBRL DOCUMENT v3.20.2
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS - Consolidated Statement of Changes in Equity (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period (in shares)     683,494,944          
Beginning of period $ 7,730 $ 7,593 $ 7,912 $ 7,866        
Treasury stock, shares (in shares) 173,312,541   173,312,541     177,340,358    
Adoption of new accounting standards     $ (4) 0        
Net income $ 247 313 580 655        
Other comprehensive income (loss) 189 (4) (278) $ (102)        
Purchases of treasury stock (in shares)       (9,500,000)        
Purchases of treasury stock   (111)   $ (697)        
Stock issued under employee benefit plans and other 120 123 187 289        
Dividends declared on common stock $ (126) (112) $ (237) (210)        
Change in noncontrolling interests   1   2        
End of period (in shares) 683,494,944   683,494,944          
End of period $ 8,160 $ 7,803 $ 8,160 $ 7,803        
Common stock                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period (in shares) 683,000,000 683,000,000 683,000,000 683,000,000        
Beginning of period $ 683 $ 683 $ 683 $ 683        
End of period (in shares) 683,000,000 683,000,000 683,000,000 683,000,000        
End of period $ 683 $ 683 $ 683 $ 683        
Common stock in treasury                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period $ (10,677) $ (10,284) $ (10,764) $ (9,989)        
Treasury stock, shares (in shares) 173,000,000 173,000,000 173,000,000 173,000,000 175,000,000 177,000,000 173,000,000 170,000,000
Purchases of treasury stock (in shares)   2,000,000   (10,000,000)        
Purchases of treasury stock   $ (157)   $ (743)        
Stock issued under employee benefit plans and other (in shares) 2,000,000 (2,000,000) 4,000,000 (7,000,000)        
Stock issued under employee benefit plans and other $ 80 $ 119 $ 167 $ 410        
End of period (10,597) (10,322) (10,597) (10,322)        
Additional contributed capital                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period 5,935 5,839 5,955 5,898        
Purchases of treasury stock   46   46        
Stock issued under employee benefit plans and other 40 21 20 (38)        
End of period 5,975 5,906 5,975 5,906        
Retained earnings                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period 15,935 15,414 15,718 15,075        
Adoption of new accounting standards     (4) 161        
Net income 246 313 578 655        
Stock issued under employee benefit plans and other   (17) 0 (83)        
Dividends declared on common stock (126) (112) (237) (210)        
End of period 16,055 15,598 16,055 15,598        
Accumulated other comprehensive income (loss)                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period (4,177) (4,082) (3,710) (3,823)        
Adoption of new accounting standards     0 (161)        
Other comprehensive income (loss) 189 (4) (278) (102)        
End of period (3,988) (4,086) (3,988) (4,086)        
Total Baxter stockholders' equity                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period 7,699 7,570 7,882 7,844        
Net income 246 313 578 655        
Other comprehensive income (loss) 189 (4) (278) (102)        
Purchases of treasury stock   (111)   (697)        
Stock issued under employee benefit plans and other 120 123 187 289        
Dividends declared on common stock (126) (112) (237) (210)        
End of period 8,128 7,779 8,128 7,779        
Noncontrolling interests                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period 31 23 30 22        
Net income 1   2          
Change in noncontrolling interests   1   2        
End of period $ 32 24 $ 32 24        
As previously reported                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   7,669   7,816        
Adoption of new accounting standards       0        
Net income   343   690        
Other comprehensive income (loss)   (77)   (54)        
Purchases of treasury stock   (111)   (697)        
Stock issued under employee benefit plans and other   123   289        
Dividends declared on common stock   (112)   (210)        
Change in noncontrolling interests   1   2        
End of period   $ 7,836   $ 7,836        
As previously reported | Common stock                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period (in shares)   683,000,000   683,000,000        
Beginning of period   $ 683   $ 683        
End of period (in shares)   683,000,000   683,000,000        
End of period   $ 683   $ 683        
As previously reported | Common stock in treasury                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   $ (10,284)   $ (9,989)        
Treasury stock, shares (in shares)   173,000,000   173,000,000     173,000,000 170,000,000
Purchases of treasury stock (in shares)   2,000,000   10,000,000        
Purchases of treasury stock   $ (157)   $ (743)        
Stock issued under employee benefit plans and other (in shares)   (2,000,000)   (7,000,000)        
Stock issued under employee benefit plans and other   $ 119   $ 410        
End of period   (10,322)   (10,322)        
As previously reported | Additional contributed capital                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   5,839   5,898        
Purchases of treasury stock       46        
Stock issued under employee benefit plans and other   21   (38)        
End of period   5,906   5,906        
As previously reported | Retained earnings                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   15,970   15,626        
Adoption of new accounting standards       161        
Net income   343   690        
Stock issued under employee benefit plans and other   (17)   (83)        
Dividends declared on common stock   (112)   (210)        
End of period   16,184   16,184        
As previously reported | Accumulated other comprehensive income (loss)                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   (4,562)   (4,424)        
Adoption of new accounting standards       (161)        
Other comprehensive income (loss)   (77)   (54)        
End of period   (4,639)   (4,639)        
As previously reported | Total Baxter stockholders' equity                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   7,646   7,794        
Net income   343   690        
Other comprehensive income (loss)   (77)   (54)        
Purchases of treasury stock   (111)   (697)        
Stock issued under employee benefit plans and other   123   289        
Dividends declared on common stock   (112)   (210)        
End of period   7,812   7,812        
As previously reported | Noncontrolling interests                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   23   22        
Change in noncontrolling interests   1   2        
End of period   24   24        
Restatement impacts                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   (76)   50        
Net income   (30)   (35)        
Other comprehensive income (loss)   73   (48)        
End of period   $ (33)   $ (33)        
Restatement impacts | Common stock                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period (in shares)   0   0        
Beginning of period   $ 0   $ 0        
End of period (in shares)   0   0        
End of period   $ 0   $ 0        
Restatement impacts | Common stock in treasury                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   $ 0   $ 0        
Treasury stock, shares (in shares)   0   0     0 0
End of period   $ 0   $ 0        
Restatement impacts | Additional contributed capital                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   0   0        
End of period   0   0        
Restatement impacts | Retained earnings                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   (556)   (551)        
Net income   (30)   (35)        
End of period   (586)   (586)        
Restatement impacts | Accumulated other comprehensive income (loss)                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   480   601        
Other comprehensive income (loss)   73   (48)        
End of period   553   553        
Restatement impacts | Total Baxter stockholders' equity                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   (76)   50        
Net income   (30)   (35)        
Other comprehensive income (loss)   73   (48)        
End of period   (33)   (33)        
Restatement impacts | Noncontrolling interests                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning of period   0   0        
End of period   $ 0   $ 0